RecruitingNot ApplicableNCT07506044

Dexmedetomidine as an Adjuvant During Dural Puncture Epidural

The Effect of Different Doses of Dexmedetomidine as an Adjuvant to Bupivacaine for Parturients Having Dural Puncture Epidural Technique to Elaborate Labor Pain


Sponsor

Menoufia University

Enrollment

140 participants

Start Date

Feb 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The study aimed to determine the effects of using varied doses of DEX on the concentration of bupivacaine injected for epidural labor analgesia, and to assess the benefits of the dural puncture epidural.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 40 Years

Inclusion Criteria1

  • Women who attend the Emergency Department in labor, with cervical dilation of 3-5 cm,

Exclusion Criteria6

  • Abnormal fetal presentation or lie, 'premature rupture of membranes, maternal fever, fetal distress, pregnancy-induced diseases
  • abnormal placental position,
  • ASA grade>II
  • marked obesity,
  • allergy or contraindications to the used drugs,
  • spinal deformity or disorders 'cutaneous diseases or infection at the injection site

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEEpidural Catheter with bupivacaine

epidural injection of plain Bup

DEVICEEpidural with dural puncture

the dura is punctured by a 26-G spinal needle using the needle-through-needle technique, and is withdrawn after confirmation of free-flowing cerebrospinal fluid,

DRUGDexmedetomidine 0.4 added

Dexmedetomidine 0.4 added

DRUGDexmedetomidine 0.6 added

Dexmedetomidine 0.6 added


Locations(1)

Faculty of Medicine Menoufia University

Shebeen El Kom, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07506044